John Frelinger
Concepts (417)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Sialoglycoproteins | 12 | 1989 | 31 |
Why?
| Antigens, CD | 15 | 1989 | 128 |
Why?
| Prostate-Specific Antigen | 10 | 1996 | 34 |
Why?
| Epitopes, T-Lymphocyte | 4 | 2000 | 17 |
Why?
| Mice | 80 | 1979 | 623 |
Why?
| Interleukin-2 | 11 | 1983 | 71 |
Why?
| Antigen Presentation | 9 | 1996 | 28 |
Why?
| Antigen-Presenting Cells | 11 | 1983 | 40 |
Why?
| CD4-Positive T-Lymphocytes | 5 | 1993 | 113 |
Why?
| Mice, Inbred BALB C | 35 | 1984 | 176 |
Why?
| T-Lymphocytes, Cytotoxic | 17 | 1984 | 52 |
Why?
| Bacterial Proteins | 2 | 2009 | 99 |
Why?
| Animals | 85 | 1979 | 1031 |
Why?
| T-Lymphocytes | 16 | 1982 | 182 |
Why?
| Herpesvirus 1, Human | 3 | 2001 | 28 |
Why?
| Interleukin-3 | 6 | 1993 | 19 |
Why?
| Tularemia | 2 | 2009 | 4 |
Why?
| Francisella tularensis | 2 | 2009 | 3 |
Why?
| Lung Neoplasms | 13 | 1987 | 159 |
Why?
| Mice, Inbred C57BL | 23 | 1988 | 318 |
Why?
| Interferon-gamma | 11 | 1988 | 133 |
Why?
| Cytotoxicity, Immunologic | 10 | 1981 | 54 |
Why?
| Lymphocytes, Tumor-Infiltrating | 10 | 1993 | 20 |
Why?
| Histocompatibility Antigens Class I | 11 | 1990 | 32 |
Why?
| H-2 Antigens | 10 | 1981 | 12 |
Why?
| Lymphocyte Activation | 12 | 1982 | 137 |
Why?
| Transfection | 25 | 1984 | 237 |
Why?
| Protein Array Analysis | 1 | 2011 | 13 |
Why?
| Mice, Transgenic | 14 | 1995 | 209 |
Why?
| Tissue Kallikreins | 2 | 1998 | 7 |
Why?
| Neoplasms, Experimental | 6 | 1993 | 72 |
Why?
| Recombinant Proteins | 6 | 1991 | 290 |
Why?
| Hybridomas | 7 | 1983 | 31 |
Why?
| Tumor Cells, Cultured | 15 | 1988 | 233 |
Why?
| Melanoma, Experimental | 5 | 2003 | 13 |
Why?
| Gene Expression | 7 | 1990 | 291 |
Why?
| B-Lymphocytes | 7 | 1980 | 134 |
Why?
| Immunodominant Epitopes | 1 | 2009 | 14 |
Why?
| Dendritic Cells | 4 | 1993 | 60 |
Why?
| Antigens, CD43 | 12 | 1989 | 9 |
Why?
| Immunotherapy | 5 | 1993 | 48 |
Why?
| Antibodies, Monoclonal | 13 | 1982 | 241 |
Why?
| Immunization | 3 | 1991 | 85 |
Why?
| Lipoproteins | 1 | 2009 | 52 |
Why?
| Carcinoma | 7 | 1987 | 109 |
Why?
| Prostatic Neoplasms | 4 | 1996 | 120 |
Why?
| T-Lymphocyte Subsets | 2 | 1993 | 70 |
Why?
| Histocompatibility Antigens Class II | 11 | 1981 | 50 |
Why?
| Spleen | 10 | 1980 | 129 |
Why?
| Genes, Reporter | 1 | 2007 | 111 |
Why?
| Neoplasms | 3 | 1998 | 239 |
Why?
| Clonal Anergy | 2 | 2000 | 20 |
Why?
| Antigens, Surface | 4 | 1979 | 51 |
Why?
| Immunoblotting | 4 | 1990 | 119 |
Why?
| Immunologic Deficiency Syndromes | 2 | 1988 | 30 |
Why?
| Cancer Vaccines | 2 | 1999 | 21 |
Why?
| Interleukin-12 | 3 | 2003 | 27 |
Why?
| Histidine | 1 | 2001 | 42 |
Why?
| Wiskott-Aldrich Syndrome | 2 | 1990 | 6 |
Why?
| Green Fluorescent Proteins | 8 | 2000 | 105 |
Why?
| Regulatory Sequences, Nucleic Acid | 2 | 1997 | 43 |
Why?
| Cell Line | 12 | 1988 | 375 |
Why?
| B-Lymphocyte Subsets | 1 | 2001 | 33 |
Why?
| Enzyme-Linked Immunosorbent Assay | 4 | 2000 | 224 |
Why?
| Genetic Vectors | 4 | 2000 | 139 |
Why?
| Langerhans Cells | 3 | 1979 | 13 |
Why?
| Luminescent Proteins | 5 | 2000 | 67 |
Why?
| Gene Expression Regulation | 4 | 1990 | 277 |
Why?
| Epitopes | 6 | 1980 | 86 |
Why?
| Antigens, Neoplasm | 5 | 1987 | 56 |
Why?
| Epidermis | 4 | 1979 | 30 |
Why?
| Ovalbumin | 7 | 1996 | 32 |
Why?
| Cytokines | 4 | 1995 | 207 |
Why?
| Isoantigens | 4 | 1979 | 18 |
Why?
| Macrophages | 3 | 1979 | 148 |
Why?
| Antigens, T-Independent | 1 | 1997 | 5 |
Why?
| Killer Cells, Natural | 5 | 1988 | 62 |
Why?
| Immunologic Memory | 3 | 1995 | 51 |
Why?
| Promoter Regions, Genetic | 3 | 1992 | 188 |
Why?
| Histocompatibility Antigens | 5 | 1980 | 17 |
Why?
| Transcription, Genetic | 3 | 1992 | 253 |
Why?
| Mammary Neoplasms, Experimental | 5 | 1993 | 37 |
Why?
| T-Lymphocytes, Helper-Inducer | 2 | 1983 | 38 |
Why?
| Cells, Cultured | 8 | 1984 | 447 |
Why?
| Dimethyl Sulfoxide | 4 | 1988 | 30 |
Why?
| Epitope Mapping | 2 | 2001 | 21 |
Why?
| Cell Movement | 3 | 2005 | 163 |
Why?
| Growth Inhibitors | 2 | 1999 | 33 |
Why?
| Peptides | 4 | 1980 | 154 |
Why?
| Amino Acid Sequence | 6 | 1981 | 319 |
Why?
| Male | 14 | 1981 | 1553 |
Why?
| Plasmids | 4 | 1984 | 122 |
Why?
| Lymphocyte Cooperation | 3 | 1996 | 12 |
Why?
| Humans | 20 | 1989 | 1856 |
Why?
| Gene Therapy | 4 | 1997 | 89 |
Why?
| Skin Transplantation | 3 | 1998 | 39 |
Why?
| Immunity, Cellular | 3 | 1990 | 85 |
Why?
| Membrane Glycoproteins | 2 | 1993 | 154 |
Why?
| Transforming Growth Factor beta | 3 | 1993 | 99 |
Why?
| Photochemotherapy | 2 | 2003 | 18 |
Why?
| Genes | 4 | 1981 | 82 |
Why?
| Transduction, Genetic | 2 | 2001 | 65 |
Why?
| Antibody Specificity | 3 | 1980 | 71 |
Why?
| Mice, Knockout | 5 | 1998 | 265 |
Why?
| Major Histocompatibility Complex | 7 | 1979 | 23 |
Why?
| Enhancer Elements, Genetic | 3 | 1995 | 43 |
Why?
| Gene Transfer Techniques | 2 | 2000 | 59 |
Why?
| Hematopoietic Stem Cells | 1 | 1995 | 69 |
Why?
| Vascular Endothelial Growth Factor Receptor-3 | 2 | 2003 | 9 |
Why?
| Bone Marrow Cells | 4 | 1980 | 92 |
Why?
| Base Sequence | 7 | 1981 | 371 |
Why?
| Interleukin-2 Receptor alpha Subunit | 1 | 2011 | 9 |
Why?
| Lymphocytes | 2 | 1985 | 142 |
Why?
| Molecular Sequence Data | 6 | 1989 | 404 |
Why?
| Immunohistochemistry | 4 | 1998 | 355 |
Why?
| Graft Rejection | 5 | 1987 | 59 |
Why?
| Lymph Nodes | 6 | 1997 | 106 |
Why?
| Flow Cytometry | 5 | 1991 | 216 |
Why?
| Trypsin | 3 | 1980 | 63 |
Why?
| Prostate | 2 | 1998 | 55 |
Why?
| Antibodies, Neoplasm | 2 | 1998 | 28 |
Why?
| Cell Proliferation | 2 | 2005 | 227 |
Why?
| Sarcoma, Experimental | 2 | 1994 | 21 |
Why?
| Chromosomes, Human, Pair 16 | 1 | 1989 | 7 |
Why?
| Clone Cells | 8 | 1982 | 92 |
Why?
| Phenotype | 4 | 1980 | 303 |
Why?
| Chromosomes | 1 | 1989 | 32 |
Why?
| Cell Differentiation | 5 | 1979 | 262 |
Why?
| Blood Proteins | 1 | 1989 | 71 |
Why?
| Mice, Inbred DBA | 3 | 1996 | 38 |
Why?
| Poly I-C | 1 | 1988 | 7 |
Why?
| Neoplasm Transplantation | 6 | 1987 | 67 |
Why?
| Bone Marrow | 2 | 1979 | 109 |
Why?
| Time Factors | 3 | 1998 | 896 |
Why?
| Cell Line, Tumor | 5 | 2005 | 208 |
Why?
| Gamma Rays | 1 | 2008 | 38 |
Why?
| DNA | 3 | 1981 | 262 |
Why?
| Antigen-Antibody Complex | 2 | 1984 | 34 |
Why?
| Gene Products, gag | 1 | 2006 | 14 |
Why?
| Omentum | 1 | 2006 | 12 |
Why?
| Disease Models, Animal | 1 | 2011 | 349 |
Why?
| Gene Expression Regulation, Viral | 1 | 2006 | 21 |
Why?
| Recombinant Fusion Proteins | 2 | 1995 | 189 |
Why?
| Peritoneal Neoplasms | 1 | 2006 | 24 |
Why?
| Luciferases | 1 | 2007 | 70 |
Why?
| Virion | 1 | 2007 | 24 |
Why?
| Genes, MHC Class II | 2 | 1984 | 17 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2006 | 25 |
Why?
| RNA, Messenger | 6 | 1981 | 394 |
Why?
| Xenopus laevis | 1 | 2007 | 49 |
Why?
| Electrophoresis, Polyacrylamide Gel | 4 | 1980 | 167 |
Why?
| Biopsy | 1 | 2007 | 207 |
Why?
| Binding Sites, Antibody | 1 | 1985 | 28 |
Why?
| Thymus Gland | 2 | 1990 | 57 |
Why?
| Lipopolysaccharides | 2 | 1996 | 98 |
Why?
| Papillomaviridae | 1 | 2007 | 37 |
Why?
| Antineoplastic Agents | 1 | 2011 | 190 |
Why?
| Lymphoid Tissue | 1 | 2005 | 34 |
Why?
| Endopeptidase K | 1 | 2004 | 6 |
Why?
| Enzymes, Immobilized | 1 | 2004 | 7 |
Why?
| Membrane Proteins | 1 | 2009 | 233 |
Why?
| Glycoproteins | 2 | 1988 | 113 |
Why?
| Pseudomonas aeruginosa | 1 | 2006 | 33 |
Why?
| Cloning, Molecular | 5 | 1981 | 183 |
Why?
| Isoantibodies | 2 | 1980 | 25 |
Why?
| Mesoporphyrins | 1 | 2003 | 4 |
Why?
| Microspheres | 2 | 1993 | 40 |
Why?
| Antigens | 2 | 1983 | 66 |
Why?
| HSP70 Heat-Shock Proteins | 1 | 2003 | 27 |
Why?
| Antibodies | 1 | 1984 | 159 |
Why?
| Peritoneal Cavity | 2 | 1997 | 28 |
Why?
| Microscopy, Confocal | 1 | 2004 | 105 |
Why?
| Leukocytes | 2 | 1989 | 94 |
Why?
| Antigens, CD8 | 2 | 1992 | 25 |
Why?
| Immunoglobulins | 3 | 1981 | 54 |
Why?
| Immune Tolerance | 2 | 1998 | 72 |
Why?
| Neovascularization, Pathologic | 1 | 2003 | 64 |
Why?
| Chromium Radioisotopes | 1 | 2001 | 7 |
Why?
| Molecular Weight | 4 | 1981 | 154 |
Why?
| Burns | 2 | 1998 | 20 |
Why?
| Coculture Techniques | 1 | 2001 | 59 |
Why?
| Endopeptidases | 1 | 2001 | 46 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1995 | 53 |
Why?
| HLA-A2 Antigen | 2 | 1991 | 8 |
Why?
| Gene Rearrangement, T-Lymphocyte | 1 | 2001 | 4 |
Why?
| Self Tolerance | 1 | 2001 | 4 |
Why?
| Gene Rearrangement, B-Lymphocyte | 1 | 2001 | 13 |
Why?
| Hemophilia B | 1 | 2001 | 9 |
Why?
| Factor IX | 1 | 2001 | 10 |
Why?
| Autoantigens | 1 | 2001 | 29 |
Why?
| Immunophenotyping | 3 | 1999 | 66 |
Why?
| Sequence Deletion | 1 | 2001 | 88 |
Why?
| Hemophilia A | 1 | 2001 | 23 |
Why?
| Mice, Inbred A | 5 | 1981 | 15 |
Why?
| Blotting, Western | 3 | 1988 | 275 |
Why?
| Blood Cells | 1 | 2000 | 19 |
Why?
| Herpesvirus 7, Human | 1 | 2001 | 11 |
Why?
| Conjunctiva | 1 | 2000 | 19 |
Why?
| HIV-1 | 1 | 2006 | 93 |
Why?
| Viral Envelope Proteins | 1 | 2001 | 26 |
Why?
| Nucleic Acid Hybridization | 3 | 1981 | 94 |
Why?
| Indicators and Reagents | 1 | 2000 | 79 |
Why?
| Protein Biosynthesis | 2 | 1981 | 113 |
Why?
| Tissue Donors | 1 | 2000 | 41 |
Why?
| Sequence Homology, Nucleic Acid | 2 | 1990 | 88 |
Why?
| Genes, MHC Class I | 2 | 1988 | 11 |
Why?
| Postoperative Care | 1 | 2000 | 84 |
Why?
| Hybridization, Genetic | 2 | 1982 | 12 |
Why?
| Chromosome Mapping | 3 | 1981 | 107 |
Why?
| Radiation Tolerance | 1 | 2000 | 37 |
Why?
| Neoplasm Metastasis | 3 | 1990 | 112 |
Why?
| Factor VIII | 1 | 2001 | 28 |
Why?
| Epithelial Cells | 1 | 2001 | 135 |
Why?
| Cell Adhesion | 2 | 1996 | 113 |
Why?
| Mice, Inbred C3H | 2 | 1993 | 86 |
Why?
| Transgenes | 1 | 1998 | 56 |
Why?
| Cell Survival | 2 | 1995 | 229 |
Why?
| Models, Biological | 3 | 1991 | 410 |
Why?
| Escherichia coli | 1 | 2001 | 143 |
Why?
| Models, Genetic | 1 | 1998 | 90 |
Why?
| Ficoll | 1 | 1997 | 4 |
Why?
| Bone Marrow Transplantation | 1 | 2000 | 90 |
Why?
| Polymorphism, Genetic | 4 | 1981 | 94 |
Why?
| Genitalia, Male | 1 | 1997 | 12 |
Why?
| T-Lymphocytes, Regulatory | 1 | 1998 | 32 |
Why?
| Endothelium, Lymphatic | 1 | 1997 | 4 |
Why?
| Receptors, Lymphocyte Homing | 1 | 1997 | 10 |
Why?
| Female | 9 | 1982 | 1643 |
Why?
| Genes, Immunoglobulin | 1 | 1997 | 28 |
Why?
| Keratinocytes | 1 | 1998 | 36 |
Why?
| Interleukin-4 | 2 | 1993 | 62 |
Why?
| Restriction Mapping | 1 | 1997 | 74 |
Why?
| Immunosuppression | 1 | 1997 | 47 |
Why?
| Hemocyanin | 1 | 1996 | 16 |
Why?
| Organ Specificity | 1 | 1997 | 104 |
Why?
| Tumor Markers, Biological | 1 | 2000 | 112 |
Why?
| Mast-Cell Sarcoma | 1 | 1996 | 9 |
Why?
| Mice, Nude | 2 | 2003 | 72 |
Why?
| Fibroblasts | 2 | 1990 | 179 |
Why?
| Antibody Formation | 1 | 1997 | 89 |
Why?
| Immunoglobulin M | 1 | 1996 | 81 |
Why?
| Microscopy, Immunoelectron | 1 | 1996 | 22 |
Why?
| Signal Transduction | 1 | 2006 | 313 |
Why?
| Immunoconjugates | 1 | 1995 | 11 |
Why?
| Mice, Inbred Strains | 5 | 1982 | 118 |
Why?
| Antigens, CD80 | 1 | 1995 | 19 |
Why?
| Antigens, Thy-1 | 2 | 1990 | 22 |
Why?
| DNA Primers | 1 | 1997 | 208 |
Why?
| Trans-Activators | 1 | 1999 | 113 |
Why?
| beta 2-Microglobulin | 2 | 1981 | 17 |
Why?
| Nuclear Proteins | 1 | 1999 | 139 |
Why?
| Up-Regulation | 2 | 2006 | 183 |
Why?
| Rats | 7 | 1980 | 530 |
Why?
| Polymerase Chain Reaction | 1 | 1997 | 279 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1999 | 121 |
Why?
| Binding, Competitive | 2 | 1984 | 109 |
Why?
| Cell Count | 1 | 1995 | 163 |
Why?
| Immune Sera | 3 | 1980 | 56 |
Why?
| Tissue Distribution | 2 | 1988 | 124 |
Why?
| Vascular Endothelial Growth Factor A | 2 | 2003 | 94 |
Why?
| RNA, Neoplasm | 1 | 1993 | 41 |
Why?
| Endothelial Growth Factors | 2 | 2003 | 47 |
Why?
| Cell Separation | 1 | 1993 | 110 |
Why?
| Cell Hypoxia | 2 | 1998 | 31 |
Why?
| Endothelium, Vascular | 2 | 2003 | 139 |
Why?
| Antigens, CD4 | 1 | 1992 | 29 |
Why?
| Chloramphenicol O-Acetyltransferase | 1 | 1992 | 21 |
Why?
| Dosage Compensation, Genetic | 1 | 1992 | 8 |
Why?
| Peyer's Patches | 2 | 1997 | 7 |
Why?
| Oxygen | 2 | 2003 | 179 |
Why?
| Rats, Inbred BN | 5 | 1980 | 9 |
Why?
| X Chromosome | 1 | 1992 | 24 |
Why?
| Cell Line, Transformed | 1 | 1992 | 52 |
Why?
| Fluorescent Dyes | 2 | 2001 | 115 |
Why?
| Kinetics | 2 | 2004 | 349 |
Why?
| Herpesvirus 4, Human | 1 | 1992 | 34 |
Why?
| Genetic Linkage | 1 | 1992 | 57 |
Why?
| Fetus | 1 | 1993 | 105 |
Why?
| Heterozygote | 1 | 1992 | 80 |
Why?
| Protein Conformation | 4 | 1981 | 123 |
Why?
| Radiation Chimera | 2 | 1979 | 11 |
Why?
| Poly A | 1 | 1990 | 16 |
Why?
| Cross Reactions | 1 | 1990 | 63 |
Why?
| Multigene Family | 1 | 1990 | 52 |
Why?
| Mutagenesis, Site-Directed | 1 | 1991 | 126 |
Why?
| Interleukin-1 | 1 | 1990 | 109 |
Why?
| Karyotyping | 1 | 1989 | 47 |
Why?
| Cell Communication | 1 | 2010 | 72 |
Why?
| Rabbits | 2 | 1981 | 252 |
Why?
| Apoptosis | 1 | 1995 | 265 |
Why?
| Mice, Inbred CBA | 2 | 1998 | 41 |
Why?
| Haploidy | 2 | 1980 | 7 |
Why?
| Neuraminidase | 1 | 1988 | 12 |
Why?
| Lectins | 1 | 1988 | 18 |
Why?
| Concanavalin A | 1 | 1988 | 25 |
Why?
| Glycoside Hydrolases | 1 | 1988 | 20 |
Why?
| Antigen-Antibody Reactions | 2 | 1984 | 31 |
Why?
| Rats, Inbred BUF | 3 | 1981 | 5 |
Why?
| Immunity, Innate | 1 | 1988 | 60 |
Why?
| Pregnancy | 1 | 1993 | 455 |
Why?
| Genes, gag | 1 | 2006 | 6 |
Why?
| Capsid Proteins | 1 | 2007 | 19 |
Why?
| 3T3 Cells | 1 | 2006 | 54 |
Why?
| Oncogene Proteins, Viral | 1 | 2007 | 29 |
Why?
| Dihematoporphyrin Ether | 1 | 2006 | 8 |
Why?
| Vascular Cell Adhesion Molecule-1 | 1 | 2006 | 27 |
Why?
| Models, Immunological | 1 | 2006 | 40 |
Why?
| Epithelium | 1 | 2006 | 101 |
Why?
| AIDS Vaccines | 1 | 2006 | 18 |
Why?
| Porins | 1 | 2006 | 11 |
Why?
| Regulon | 1 | 2006 | 9 |
Why?
| Infant | 1 | 1992 | 464 |
Why?
| Gene Conversion | 1 | 1985 | 4 |
Why?
| Evolution, Molecular | 1 | 2006 | 45 |
Why?
| Cytotoxicity Tests, Immunologic | 1 | 2005 | 23 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 1990 | 210 |
Why?
| Lymphocyte Count | 1 | 2005 | 38 |
Why?
| Specific Pathogen-Free Organisms | 1 | 2005 | 26 |
Why?
| Virulence Factors | 1 | 2006 | 24 |
Why?
| DNA, Recombinant | 2 | 1981 | 34 |
Why?
| Mice, Mutant Strains | 1 | 1985 | 77 |
Why?
| Immunologic Factors | 1 | 2006 | 46 |
Why?
| Child, Preschool | 1 | 1992 | 554 |
Why?
| Dinoprostone | 1 | 2006 | 55 |
Why?
| Rats, Inbred WF | 2 | 1981 | 2 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2005 | 85 |
Why?
| Boron Compounds | 1 | 2004 | 9 |
Why?
| Repressor Proteins | 1 | 2007 | 96 |
Why?
| Fluorescence Polarization | 1 | 2004 | 7 |
Why?
| Chemical Precipitation | 2 | 1981 | 24 |
Why?
| Serum Albumin, Bovine | 1 | 2004 | 29 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2006 | 26 |
Why?
| RNA | 1 | 1988 | 126 |
Why?
| Microscopy, Fluorescence | 1 | 2005 | 137 |
Why?
| Chemokine CXCL10 | 1 | 2003 | 22 |
Why?
| Vascular Endothelial Growth Factors | 1 | 2003 | 39 |
Why?
| Vascular Endothelial Growth Factor D | 1 | 2003 | 6 |
Why?
| Vascular Endothelial Growth Factor C | 1 | 2003 | 13 |
Why?
| Light | 1 | 2003 | 64 |
Why?
| Transplantation, Homologous | 2 | 1987 | 94 |
Why?
| DNA Replication | 1 | 1984 | 75 |
Why?
| Cell Nucleus | 1 | 2006 | 169 |
Why?
| Cell Death | 1 | 2003 | 94 |
Why?
| Lymphokines | 1 | 2003 | 61 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 64 |
Why?
| Anoxia | 1 | 2003 | 85 |
Why?
| Receptors, Antigen, T-Cell | 1 | 1983 | 34 |
Why?
| Genetic Code | 1 | 1981 | 10 |
Why?
| Substrate Specificity | 1 | 2001 | 90 |
Why?
| Immunoglobulin Isotypes | 1 | 2001 | 17 |
Why?
| Aging | 1 | 2007 | 275 |
Why?
| Sensitivity and Specificity | 1 | 2004 | 427 |
Why?
| Viscera | 1 | 2000 | 8 |
Why?
| Mice, Neurologic Mutants | 1 | 2000 | 8 |
Why?
| Chromatography, High Pressure Liquid | 1 | 1981 | 121 |
Why?
| Thrombin | 1 | 2001 | 41 |
Why?
| Rats, Inbred F344 | 2 | 1981 | 80 |
Why?
| Mucous Membrane | 1 | 2000 | 37 |
Why?
| Cell Division | 1 | 2003 | 273 |
Why?
| Submandibular Gland | 1 | 2000 | 20 |
Why?
| Peripheral Nerves | 1 | 2000 | 26 |
Why?
| Injections, Subcutaneous | 1 | 2000 | 63 |
Why?
| Dose-Response Relationship, Drug | 1 | 2003 | 431 |
Why?
| Administration, Topical | 1 | 2000 | 57 |
Why?
| Adjuvants, Immunologic | 1 | 2001 | 73 |
Why?
| Antigens, Viral | 1 | 2001 | 53 |
Why?
| Immunization, Secondary | 1 | 2000 | 31 |
Why?
| Thymidine Kinase | 2 | 1984 | 15 |
Why?
| Transplantation, Heterologous | 1 | 2000 | 57 |
Why?
| Antigens, CD86 | 1 | 1999 | 7 |
Why?
| Lymphocyte Culture Test, Mixed | 1 | 1999 | 21 |
Why?
| Mice, SCID | 1 | 2000 | 61 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2000 | 23 |
Why?
| Melanoma | 1 | 2001 | 87 |
Why?
| Central Nervous System | 1 | 2000 | 77 |
Why?
| Drug Synergism | 1 | 1999 | 104 |
Why?
| Receptors, Interleukin-2 | 1 | 1998 | 31 |
Why?
| ATP-Binding Cassette Transporters | 1 | 1999 | 33 |
Why?
| Reference Values | 1 | 2000 | 278 |
Why?
| Immunoglobulin G | 1 | 2001 | 191 |
Why?
| Transplantation, Autologous | 1 | 1998 | 78 |
Why?
| Tail | 1 | 1998 | 16 |
Why?
| Antibodies, Viral | 1 | 2001 | 104 |
Why?
| Graft Survival | 1 | 1998 | 74 |
Why?
| Mutagenesis | 1 | 1998 | 74 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 1998 | 91 |
Why?
| Molecular Conformation | 2 | 1981 | 31 |
Why?
| Structure-Activity Relationship | 2 | 1981 | 124 |
Why?
| CTLA-4 Antigen | 1 | 1995 | 10 |
Why?
| Eosinophils | 1 | 1995 | 30 |
Why?
| Antigens, Differentiation | 1 | 1995 | 53 |
Why?
| Interleukins | 1 | 1995 | 32 |
Why?
| Immunosorbent Techniques | 1 | 1993 | 22 |
Why?
| Ganciclovir | 1 | 1993 | 18 |
Why?
| Simplexvirus | 1 | 1993 | 33 |
Why?
| Mutation | 2 | 1990 | 340 |
Why?
| Magnetics | 1 | 1993 | 30 |
Why?
| Codon | 1 | 1991 | 41 |
Why?
| Rats, Inbred Lew | 2 | 1980 | 17 |
Why?
| Interferons | 1 | 1990 | 39 |
Why?
| Blotting, Northern | 1 | 1990 | 151 |
Why?
| Collodion | 1 | 1985 | 3 |
Why?
| Paper | 1 | 1985 | 8 |
Why?
| Precipitin Tests | 1 | 1985 | 81 |
Why?
| Species Specificity | 1 | 1985 | 186 |
Why?
| Vesicular stomatitis Indiana virus | 1 | 1984 | 13 |
Why?
| L Cells (Cell Line) | 1 | 1984 | 12 |
Why?
| Lymphocytic choriomeningitis virus | 1 | 1984 | 3 |
Why?
| DNA Restriction Enzymes | 1 | 1984 | 44 |
Why?
| Genotype | 1 | 1985 | 175 |
Why?
| Lung | 1 | 1990 | 232 |
Why?
| Immunoglobulin mu-Chains | 1 | 1981 | 10 |
Why?
| Absorption | 1 | 1981 | 38 |
Why?
| Spermatozoa | 1 | 1981 | 25 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 1981 | 48 |
Why?
| Chemical Phenomena | 1 | 1980 | 43 |
Why?
| Chemistry | 1 | 1980 | 43 |
Why?
|
|
Frelinger's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
